CHLOROTHIAZIDE AND RESERPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorothiazide And Reserpine, and when can generic versions of Chlorothiazide And Reserpine launch?
Chlorothiazide And Reserpine is a drug marketed by Hikma and is included in two NDAs.
The generic ingredient in CHLOROTHIAZIDE AND RESERPINE is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLOROTHIAZIDE AND RESERPINE?
- What are the global sales for CHLOROTHIAZIDE AND RESERPINE?
- What is Average Wholesale Price for CHLOROTHIAZIDE AND RESERPINE?
Summary for CHLOROTHIAZIDE AND RESERPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2 |
| DailyMed Link: | CHLOROTHIAZIDE AND RESERPINE at DailyMed |
US Patents and Regulatory Information for CHLOROTHIAZIDE AND RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CHLOROTHIAZIDE AND RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 088557-001 | Dec 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | CHLOROTHIAZIDE AND RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 088365-001 | Dec 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
